89 related articles for article (PubMed ID: 22285823)
1. Eicosapentaenoic acid and docosahexaenoic acid inhibit macrophage-induced gastric cancer cell migration by attenuating the expression of matrix metalloproteinase 10.
Wu MH; Tsai YT; Hua KT; Chang KC; Kuo ML; Lin MT
J Nutr Biochem; 2012 Nov; 23(11):1434-9. PubMed ID: 22285823
[TBL] [Abstract][Full Text] [Related]
2. Effects of eicosapentaenoic acid and docosahexaenoic acid on prostate cancer cell migration and invasion induced by tumor-associated macrophages.
Li CC; Hou YC; Yeh CL; Yeh SL
PLoS One; 2014; 9(6):e99630. PubMed ID: 24925287
[TBL] [Abstract][Full Text] [Related]
3. Eicosapentaenoic acid and docosahexaenoic acid modulate mitogen-activated protein kinase activity in endothelium.
Xue H; Wan M; Song D; Li Y; Li J
Vascul Pharmacol; 2006 Jun; 44(6):434-9. PubMed ID: 16616699
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of low-dose docosahexaenoic acid and eicosapentaenoic acid on the regulation of mitogenic signaling pathways in mesangial cells.
Yusufi AN; Cheng J; Thompson MA; Walker HJ; Gray CE; Warner GM; Grande JP
J Lab Clin Med; 2003 May; 141(5):318-29. PubMed ID: 12761475
[TBL] [Abstract][Full Text] [Related]
5. Docosahexaenoic acid attenuates macrophage-induced inflammation and improves insulin sensitivity in adipocytes-specific differential effects between LC n-3 PUFA.
Oliver E; McGillicuddy FC; Harford KA; Reynolds CM; Phillips CM; Ferguson JF; Roche HM
J Nutr Biochem; 2012 Sep; 23(9):1192-200. PubMed ID: 22137266
[TBL] [Abstract][Full Text] [Related]
6. N-3 long-chain polyunsaturated fatty acids inhibit smooth muscle cell migration by modulating urokinase plasminogen activator receptor through MEK/ERK-dependent and -independent mechanisms.
Whyte C; Thies F; Peyrol L; Balcerzak D
J Nutr Biochem; 2012 Nov; 23(11):1378-83. PubMed ID: 22221673
[TBL] [Abstract][Full Text] [Related]
7. Eicosapentaenoic acid and docosahexaenoic acid synergistically attenuate bile acid-induced hepatocellular apoptosis.
Tillman EM; Helms RA; Black DD
JPEN J Parenter Enteral Nutr; 2012 Jan; 36(1):36-42. PubMed ID: 22038211
[TBL] [Abstract][Full Text] [Related]
8. n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1alpha induction pathway.
Calviello G; Di Nicuolo F; Gragnoli S; Piccioni E; Serini S; Maggiano N; Tringali G; Navarra P; Ranelletti FO; Palozza P
Carcinogenesis; 2004 Dec; 25(12):2303-10. PubMed ID: 15358633
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of omega-3 fatty acid-induced growth inhibition in MDA-MB-231 human breast cancer cells.
Schley PD; Jijon HB; Robinson LE; Field CJ
Breast Cancer Res Treat; 2005 Jul; 92(2):187-95. PubMed ID: 15986129
[TBL] [Abstract][Full Text] [Related]
10. Involvement of apoptotic pathways in docosahexaenoic acid-induced benefit in prostate cancer: Pathway-focused gene expression analysis using RT
Sun Y; Jia X; Hou L; Liu X; Gao Q
Lipids Health Dis; 2017 Mar; 16(1):59. PubMed ID: 28330470
[TBL] [Abstract][Full Text] [Related]
11. CADPE inhibits PMA-stimulated gastric carcinoma cell invasion and matrix metalloproteinase-9 expression by FAK/MEK/ERK-mediated AP-1 activation.
Han H; Du B; Pan X; Liu J; Zhao Q; Lian X; Qian M; Liu M
Mol Cancer Res; 2010 Nov; 8(11):1477-88. PubMed ID: 21047770
[TBL] [Abstract][Full Text] [Related]
12. Eicosapentaenoic acid is more effective than docosahexaenoic acid in inhibiting proinflammatory mediator production and transcription from LPS-induced human asthmatic alveolar macrophage cells.
Mickleborough TD; Tecklenburg SL; Montgomery GS; Lindley MR
Clin Nutr; 2009 Feb; 28(1):71-7. PubMed ID: 19054597
[TBL] [Abstract][Full Text] [Related]
13. Eicosapentaenoic acid and docosahexaenoic acid suppress Th2 cytokine expression in RBL-2H3 basophilic leukemia cells.
Jin M; Park S; Park BK; Choi JJ; Yoon SJ; Yang M; Pyo MY
J Med Food; 2014 Feb; 17(2):198-205. PubMed ID: 24460246
[TBL] [Abstract][Full Text] [Related]
14. Docosahexaenoic acid induces apoptosis in lung cancer cells by increasing MKP-1 and down-regulating p-ERK1/2 and p-p38 expression.
Serini S; Trombino S; Oliva F; Piccioni E; Monego G; Resci F; Boninsegna A; Picci N; Ranelletti FO; Calviello G
Apoptosis; 2008 Sep; 13(9):1172-83. PubMed ID: 18679798
[TBL] [Abstract][Full Text] [Related]
15. Activator protein-1 mediates docosahexaenoic acid-induced apoptosis of human gastric cancer cells.
Lee SE; Lim JW; Kim H
Ann N Y Acad Sci; 2009 Aug; 1171():163-9. PubMed ID: 19723051
[TBL] [Abstract][Full Text] [Related]
16. [Role of Rho GTPase in inhibiting metastatic ability of human prostate cancer cell line PC-3 by omega-3 polyunsaturated fatty acid].
Yi L; Zhang QY; Mi MT
Ai Zheng; 2007 Dec; 26(12):1281-6. PubMed ID: 18076787
[TBL] [Abstract][Full Text] [Related]
17. Docosahexaenoic acid and eicosapentaenoic acid reduce C-reactive protein expression and STAT3 activation in IL-6-treated HepG2 cells.
Wang TM; Hsieh SC; Chen JW; Chiang AN
Mol Cell Biochem; 2013 May; 377(1-2):97-106. PubMed ID: 23361365
[TBL] [Abstract][Full Text] [Related]
18. N-3 fatty acids inhibit vascular calcification via the p38-mitogen-activated protein kinase and peroxisome proliferator-activated receptor-gamma pathways.
Abedin M; Lim J; Tang TB; Park D; Demer LL; Tintut Y
Circ Res; 2006 Mar; 98(6):727-9. PubMed ID: 16514067
[TBL] [Abstract][Full Text] [Related]
19. Overexpression and hyperactivity of breast cancer-associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal alpha-linolenic and gamma-linolenic fatty acids: a novel mechanism by which dietary fat can alter mammary tumorigenesis.
Menendez JA; Ropero S; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Jun; 24(6):1369-83. PubMed ID: 15138577
[TBL] [Abstract][Full Text] [Related]
20. Benzyl isothiocyanate (BITC) inhibits migration and invasion of human gastric cancer AGS cells via suppressing ERK signal pathways.
Ho CC; Lai KC; Hsu SC; Kuo CL; Ma CY; Lin ML; Yang JS; Chung JG
Hum Exp Toxicol; 2011 Apr; 30(4):296-306. PubMed ID: 20498032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
